BKV Industries (519500)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive book value of ₹2.80 per share provides some tangible asset backing.
• ROCE is marginally positive at 0.22%, so the capital base is not being deeply eroded at the operating level.
• As a listed micro-cap with a market cap of ₹19 crore, any genuine operational revival would be easy to monitor and could move the numbers visibly.

Concerns

• Latest quarter shows zero sales and zero net profit; there is no demonstrated earning power.
• Negative ROE of -1.65% while the stock trades at 4.50 times book value means investors pay a rich price for weak asset returns.
• Piotroski F-Score of 3/9 indicates poor financial health.
• No dividend, no reported sales/profit growth, and no promoter holding disclosure reduce confidence further.

AI Analysis

I start every analysis by asking what this business will earn, on average, five years from now. For BKV Industries, I cannot even answer what it earned last quarter: the latest quarter shows ₹0 crore sales and ₹0 crore net profit. A P/E of 0.00 is not cheap; it is meaningless without an E. There is no earnings stream to value. The market cap of ₹19 crore is real, but the earnings behind it are not. Book value is ₹2.80 per share, so at ₹12.60 I am paying 4.5 times book for a company that produced a negative return on equity of -1.65%. The return on capital employed, 0.22%, barely covers anything; this is not a compounding machine. Sales growth and profit growth are both zero, dividend yield is zero, and the Piotroski F-Score of 3/9 is a warning flag, not a hidden gem signal. There is no promoter holding data and no FairStock score due to insufficient information. In Graham's language, the stock is more speculative than investment. The 52-week range of ₹7.36 to ₹13.10 shows traders have pushed the price near the top, but price action does not create intrinsic value. I would need evidence of a genuine business plan, real sales, positive margins, and honest capital allocation before I could treat BKV as a turnaround. Without those, the margin of safety is absent. Speculation may reward someone, but it is not my game. I will wait on the sideline until the figures show something I can value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer